Welcome! If you have a coupon code, click here to apply it. Apply
stock
Kazia Therapeutics Ltd ADR
NASDAQ | KZIA
9.07
USD
0.00 ( 0.00%)
AT CLOSE (AS OF Jun 13, 2025)
$13M
MARKET CAP
-
P/E Ratio
-29.13
EPS
$79
52 Week High
$2.9
52 Week Low
LIFE SCIENCES
Sector
KZIA Chart
Recent Chart
Price Action
1D
Candles
Trade Smarter
Automate your trading workflow with powerful tools — built for serious traders.
KZIA Technicals
KZIA Earnings
Yearly Income Statement (As of Jun 30, 2024)
| Field | Value (AUD) |
|---|---|
| Gross Profit | $2.3M |
| Total Revenue | $2.3M |
| Cost Of Revenue | - |
| Costof Goods And Services Sold | - |
| Operating Income | -$29M |
| Selling General And Administrative | $14M |
| Research And Development | $17M |
| Operating Expenses | $2.3M |
| Investment Income Net | - |
| Net Interest Income | $12K |
| Interest Income | $12K |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $1.9M |
| Income Before Tax | -$27M |
| Income Tax Expense | -$271K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$27M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$29M |
| Ebitda | -$27M |
| Net Income | -$27M |
Revenue & Profitability
Earnings Performance
KZIA Financials
yearly Balance Sheet (As of Jun 30, 2024)
| Field | Value (AUD) |
|---|---|
| Total Assets | $22M |
| Total Current Assets | $6.1M |
| Cash And Cash Equivalents At Carrying Value | $1.7M |
| Cash And Short Term Investments | $1.7M |
| Inventory | - |
| Current Net Receivables | $133K |
| Total Non Current Assets | $15M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $15M |
| Intangible Assets Excluding Goodwill | $15M |
| Goodwill | - |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $591K |
| Other Non Current Assets | - |
| Total Liabilities | $32M |
| Total Current Liabilities | $26M |
| Current Accounts Payable | $4.5M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $634K |
| Total Non Current Liabilities | $5.8M |
| Capital Lease Obligations | - |
| Long Term Debt | - |
| Current Long Term Debt | $634K |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $634K |
| Other Current Liabilities | $21M |
| Other Non Current Liabilities | $3.8M |
| Total Shareholder Equity | -$10M |
| Treasury Stock | - |
| Retained Earnings | -$115M |
| Common Stock | $102M |
| Common Stock Shares Outstanding | $480K |
yearly Cash Flow (As of Jun 30, 2024)
| Field | Value (AUD) |
|---|---|
| Operating Cashflow | -$9.6M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $1.9M |
| Capital Expenditures | $0 |
| Change In Receivables | - |
| Change In Inventory | - |
| Profit Loss | - |
| Cashflow From Investment | - |
| Cashflow From Financing | $6M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$27M |
yearly Income Statement (As of Jun 30, 2024)
| Field | Value (AUD) |
|---|---|
| Gross Profit | $2.3M |
| Total Revenue | $2.3M |
| Cost Of Revenue | - |
| Costof Goods And Services Sold | - |
| Operating Income | -$29M |
| Selling General And Administrative | $14M |
| Research And Development | $17M |
| Operating Expenses | $2.3M |
| Investment Income Net | - |
| Net Interest Income | $12K |
| Interest Income | $12K |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $1.9M |
| Income Before Tax | -$27M |
| Income Tax Expense | -$271K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$27M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$29M |
| Ebitda | -$27M |
| Net Income | -$27M |
KZIA News
KZIA Profile
Kazia Therapeutics Ltd ADR Profile
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS
Kazia Therapeutics Limited, a biotechnology company focused on oncology, develops anticancer drugs. The company is headquartered in Sydney, Australia.
HCTI 226.09%
$0.03
CGBS 60.00%
$0.1344
GNLN -22.08%
$0.012
IXHL 14.57%
$0.2336
GME -22.45%
$22.14
ENCP 34.21%
$0.0863
TSLA -2.24%
$319.11
CGTL 98.29%
$1.83
RGTI -3.35%
$12.1
EONR 46.20%
$0.7032
ONCO 7.70%
$0.0741
SOFI -1.06%
$14.9
BTE -1.47%
$2.01
VHAI 0.00%
$0.0006
AXDX -61.36%
$0.034
LCID -0.92%
$2.16
BTG 3.34%
$3.71
PLTR -0.88%
$135.19
ORCL 13.31%
$199.86
LYT -16.78%
$0.0982
CAN -3.63%
$0.7016
JWN 0.08%
$24.66
TDTH -30.29%
$0.2232
AAPL 0.21%
$199.2
PFE 1.47%
$24.84
BBD 1.01%
$3
RBNE
260.30%
$12.07
PBR 2.73%
$12.4
HSDT -45.89%
$0.6006
ACHR -14.79%
$9.9946
HIMS -0.71%
$57.15
NVDA -1.52%
$142.79
HBAN -0.81%
$15.96
DFS -0.21%
$200.05
PCG -0.63%
$14.3
BAC -0.25%
$44.62
SNAP -3.15%
$8.3
ME -21.26%
$0.6063
CUTR -10.19%
$0.0969
RXRX -4.26%
$5.17
KVUE 0.87%
$22.04
ITUB 0.46%
$6.61
IPG -0.51%
$23.64
NCNA -12.76%
$0.1326
MP 13.88%
$29.2
FFAI -11.05%
$1.53
AFMD -34.95%
$0.1815
VALE -0.73%
$9.54
T -0.25%
$28.27
CVAC 37.59%
$5.6
SOUN -2.77%
$9.47
GOOGL -0.93%
$175.7
WLGS -15.56%
$0.0635
CLSK -2.61%
$9.71
CIFR -5.88%
$3.84
MSFT 1.32%
$478.87
BERY -2.93%
$67.58
NUVB -17.73%
$1.81
AAOI 3.68%
$16.92
FSM 0.00%
$6.88
HL -1.32%
$5.99
SMR -2.93%
$40.38
XOM 0.38%
$109.73
TLRY -2.23%
$0.4163
SBET -65.62%
$11.185
INTS -44.73%
$0.32
UNH 2.56%
$318.5
CVE 0.70%
$14.42
PLUG -1.15%
$1.285
CX 0.43%
$6.99
CRWV
-0.49%
$148.97
CSCO 1.42%
$65.1
NIO -2.07%
$3.545
HLN 0.92%
$11.01
PTN -44.65%
$0.0941
NOK 0.76%
$5.32
BLDP -0.60%
$1.67
SBSW 2.87%
$7.18
ZAPP -46.31%
$0.1548
IOVA 3.13%
$2.31
CRCL
-9.10%
$106.54
NUWE -14.82%
$0.3143
MRK 1.87%
$81.82
NEM 4.90%
$55.92
NBIS -0.57%
$50.28
CARM -9.12%
$0.5482
TIXT 23.99%
$3.67
MRVL 2.05%
$69.64
PEP 1.85%
$132.3
AIHS -39.04%
$0.6279
CHPT -2.53%
$0.7661
MLGO -4.35%
$1.1
ET 1.10%
$18.45
YHC -4.48%
$1.28
NEE 1.15%
$73.84
RZLV 10.31%
$2.14
LGMK 4.17%
$0.004
APLD -4.88%
$11.9
UUUU -0.74%
$5.37
OMC -2.88%
$71.19
HCTI 226.09%
$0.03
CGBS 60.00%
$0.1344
GNLN -22.08%
$0.012
IXHL 14.57%
$0.2336
GME -22.45%
$22.14
ENCP 34.21%
$0.0863
TSLA -2.24%
$319.11
CGTL 98.29%
$1.83
RGTI -3.35%
$12.1
EONR 46.20%
$0.7032
ONCO 7.70%
$0.0741
SOFI -1.06%
$14.9
BTE -1.47%
$2.01
VHAI 0.00%
$0.0006
AXDX -61.36%
$0.034
LCID -0.92%
$2.16
BTG 3.34%
$3.71
PLTR -0.88%
$135.19
ORCL 13.31%
$199.86
LYT -16.78%
$0.0982
CAN -3.63%
$0.7016
JWN 0.08%
$24.66
TDTH -30.29%
$0.2232
AAPL 0.21%
$199.2
PFE 1.47%
$24.84
BBD 1.01%
$3
RBNE
260.30%
$12.07
PBR 2.73%
$12.4
HSDT -45.89%
$0.6006
ACHR -14.79%
$9.9946
HIMS -0.71%
$57.15
NVDA -1.52%
$142.79
HBAN -0.81%
$15.96
DFS -0.21%
$200.05
PCG -0.63%
$14.3
BAC -0.25%
$44.62
SNAP -3.15%
$8.3
ME -21.26%
$0.6063
CUTR -10.19%
$0.0969
RXRX -4.26%
$5.17
KVUE 0.87%
$22.04
ITUB 0.46%
$6.61
IPG -0.51%
$23.64
NCNA -12.76%
$0.1326
MP 13.88%
$29.2
FFAI -11.05%
$1.53
AFMD -34.95%
$0.1815
VALE -0.73%
$9.54
T -0.25%
$28.27
CVAC 37.59%
$5.6
SOUN -2.77%
$9.47
GOOGL -0.93%
$175.7
WLGS -15.56%
$0.0635
CLSK -2.61%
$9.71
CIFR -5.88%
$3.84
MSFT 1.32%
$478.87
BERY -2.93%
$67.58
NUVB -17.73%
$1.81
AAOI 3.68%
$16.92
FSM 0.00%
$6.88
HL -1.32%
$5.99
SMR -2.93%
$40.38
XOM 0.38%
$109.73
TLRY -2.23%
$0.4163
SBET -65.62%
$11.185
INTS -44.73%
$0.32
UNH 2.56%
$318.5
CVE 0.70%
$14.42
PLUG -1.15%
$1.285
CX 0.43%
$6.99
CRWV
-0.49%
$148.97
CSCO 1.42%
$65.1
NIO -2.07%
$3.545
HLN 0.92%
$11.01
PTN -44.65%
$0.0941
NOK 0.76%
$5.32
BLDP -0.60%
$1.67
SBSW 2.87%
$7.18
ZAPP -46.31%
$0.1548
IOVA 3.13%
$2.31
CRCL
-9.10%
$106.54
NUWE -14.82%
$0.3143
MRK 1.87%
$81.82
NEM 4.90%
$55.92
NBIS -0.57%
$50.28
CARM -9.12%
$0.5482
TIXT 23.99%
$3.67
MRVL 2.05%
$69.64
PEP 1.85%
$132.3
AIHS -39.04%
$0.6279
CHPT -2.53%
$0.7661
MLGO -4.35%
$1.1
ET 1.10%
$18.45
YHC -4.48%
$1.28
NEE 1.15%
$73.84
RZLV 10.31%
$2.14
LGMK 4.17%
$0.004
APLD -4.88%
$11.9
UUUU -0.74%
$5.37
OMC -2.88%
$71.19
Discover more tools and features to empower your trading
Explore FeaturesQuotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.